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Collagen  II  autoimmune  arthritis  (CII  AIA), ~ an  experimental  model  of 
rheumatoid arthritis,  is induced in rats or mice by immunization  with heterolo- 
gous CII (1,  2). There  is considerable evidence to support the concept that  the 
initiation of disease is related to the production of a crossreactive IgG autoanti- 
body to CII, which deposits in articular cartilage and activates the complement 
cascade.  After immunization  with  heterologous CII,  arthritic  rats  produce an 
IgG antibody which is more crossreactive with rat CII than the IgG produced by 
nonarthritic rats (3). Affinity-purified rat anti-rat CII IgG will passively transfer 
arthritis  to normal rats (4).  Complement depletion inhibits the development of 
arthritis  after  active  immunization  with  CII  (3)  or  passive  transfer  with  CII 
antibody (5).  In addition, we recently have shown that in contrast to C5 normal 
Bl0.D2/new  line  mice,  C5-deficient  Bl0.D2/old  line  mice are  resistant  to ar- 
thritis by passive transfer with CII antibody, and that, when bound to cartilage 
in vitro, either rat or mouse CII antibody will activate C5 to C5a (6). 
In the murine model of CII AIA, Wooley et al. (7, 8) suggested that suscepti- 
bility to CII AIA is linked to the I-Aq haplotype of the H-2 locus of the MHC, 
which in turn  is linked to high antibody responsiveness to CII. However, these 
investigators noted that some strains produce substantial antibody responses, but 
fail to develop arthritis.  Based upon studies reported herein, we propose that the 
specific  responses  of the  complement-fixing  IgG2  subclasses,  as  well  as  the 
availability of complement C5, represent important determinants of susceptibility 
to  CII  AIA.  In  addition,  these  studies  implicate  genes  outside  the  MHC  in 
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determining susceptibility and provide additional support for an important role 
for autoantibody to CII in the initiation of arthritis in this animal model. 
Materials and Methods 
Mice.  7-8-wk-old mice were purchased from The Jackson Laboratory, Bar Harbor, 
ME.  Breeding between  C57BL/6  (B6)  and  DBA/1  (D1)  mice and  backcrosses to  D1 
[(B6D1)F~  ×  D1]  was  done at  the  Memphis  VAMC.  Complement,  specifically  C5,  is 
thought to be required for the initiation of CII AIA (6), and female mice are known to 
be relatively deficient in  C5,  as well as C6 and  C7  (9). To control for this sex-related 
difference in complement and its possible  effect on susceptibility  to CII AIA, all studies 
used  male  mice,  with  the  exception  of the  B6D1  ×  D1  backcross  study.  Only  five 
backcrosses were available and two of these were female. Since the study was performed 
primarily to  examine  the  mode of inheritance  of IgG2a autoantibody responsiveness, 
rather than the susceptibility  to arthritis of B6D1  ×  D1  backcrosses, these two females 
were included. 
Collagen.  Chick CII was extracted from sternal  cartilage and purified according to 
published methods (10).  Mouse CII was a  generous gift from Dr.  Michael  A. Cremer, 
who prepared  it according to the  same  procedures used  in  preparing chick CII. The 
purity of both preparations was confirmed by electrophoresis (10). 
Immunization.  Mice were injected subcutaneously in the tail with chick CII emulsified 
1:1  with complete Freund's adjuvant (CFA).  The CFA was prepared by grinding myco- 
bacteria in incomplete Freund's adjuvant (IFA) (Difco Laboratories, Detroit,  MI).  The 
mycobacteria were heat-killed M. tuberculosis strains C, DT, and PN (Ministry  of Agricul- 
ture, Fisheries  and Food, Central Veterinary Laboratory, Weybridge, Surrey, England). 
Each mouse received 0.1  ml chick CII/CFA containing 100/~g CII and  10,  100,  250, or 
500 #g mycobacteria as indicated in the text. 
Arthritis.  Mice were observed for 4-5 mo for the presence or absence of arthritis. An 
animal was judged to be arthritic if one or more joint regions (digits,  wrist,  ankle) were 
red and swollen. 
Purification of Chick CII Antibody.  The following procedure was used to obtain purified 
D 1 and  B6  antibody for studies  of crossreactivity and  affinity and  as  a  reference  for 
estimating IgG autoantibody subclass serum levels in individual mice as explained below. 
Chick  CII-immune mice  were  bled  from  the  retroorbital  sinus  at  7-10-d  intervals 
beginning ~30 d after immunization and ending on about day 70. Serum aliquots were 
stored at  -70°C.  Pooled serum  was incubated  with chick CII-Sepharose overnight at 
4°C. The immunosorbent was prepared according to standard procedures using CNBr- 
activated  Sepharose  4B  (Sigma  Chemical  Co.,  St.  Louis,  MO).  Unbound protein  was 
removed by washing the immunosorbent wtih 0.1  M Tris,  0.15 M sodium chloride, pH 
7.4, on a sintered glass funnel until the filtrate absorbance at 280 nm achieved constant 
background levels (<0.05 optical density units).  Chick CII antibody then was eluted with 
0.2 M glycine, pH 2.8, neutralized with 1 M Tris, pH 8, concentrated in an Amicon cell 
(Amicon Corp., Danvers, MA), dialyzed into PBS, and stored at -70°C. 
lgG Subclass Enzyme-linked Immunosorbent Assay (ELISA).  A  "sandwich" ELISA (11) 
was used in  the determination of levels  (/~g/ml) of IgG1, 2a,  2b, and  3 in  the purified 
chick CII antibody preparations.  These values  were used in  the estimation of antibody 
affinity and IgG autoantibody subclass serum levels, as explained in subsequent sections. 
96-Well microtiter plates (Nunc; Vanguard International, Neptune, NJ) were coated with 
goat anti-mouse  IgG F(ab')2-specific antibody (Cappel  Laboratories, Cochranville, PA) 
diluted  1:75 in 0.1  M sodium carbonate, pH 9.6.  Coating was done overnight at 4°C. 
The plates were washed in 0.15 M sodium chloride, 0.05% Tween-20 with a Dynawasher 
I  (Dynatech Laboratories,  Inc., Alexandria,  VA) and incubated overnight at 4°C with 
affinity-purified chick CII antibody diluted in 0.1  M Tris, 0.15 M sodium chloride, 0.5% 
Tween-20, pH 7.4 (ELISA buffer). After washing, the plates were incubated for 2 h at 
4°C with rabbit anti-mouse IgG1, 2a,  2b,  or 3 sera (Miles  Laboratories, Inc., Elkhart, 
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found  to  be  <10%  under  the  conditions  of this  subclass  ELISA on  the  basis  of their 
relative reactivities with purified mouse myeloma IgG subclass proteins (Litton Bionetics 
Inc., Kensington, MD). After washing, the plates were incubated for another 2 h at 4°C 
with peroxidase-conjugated goat anti-rabbit  IgG, Fc-specific sera (Cappell Laboratories) 
diluted  1:7000  in  ELISA  buffer,  washed  again,  and  then  incubated  with  peroxidase 
substrate  for  60  rain  at  room  temperature.  The  substrate  consisted  of 2.21  mM  0- 
phenylenediamine, 26.59 mM citric acid, 51.40 mM sodium phosphate, 0.012% hydrogen 
peroxide,  and  0.1%  Tween-20.  A  volume of 0.15  ml/well  was used  in all  incubations. 
Absorbances at 450 nm were measured with a Microelisa Auto Reader MR580 (Dynatech 
Laboratories, Inc.). 
The following procedure was used to convert absorbances to/~g/ml values for each IgG 
subclass. Various dilutions of Miles Laboratories mouse reference serum were assayed on 
the goat anti-mouse IgG F(ab')2-coated plates.  This reference serum is supplied with gg/ 
ml values for each IgG subclass. The absorbance values (y) and the corresponding log #g/ 
ml values (x) were entered into a TI-55 calculator (Texas Instruments, Inc., Dallas, TX), 
preprogrammed  to  compute  slope  (m)  and  y-intercept  (b)  values  in  the  straight  line 
equation: y =  (m)(log x) +  b. The calculator used a linear regression program to solve for 
m and b; correlation coefficients (r values) for the relationship between ELISA absorbance 
and tzg/ml values of IgG1,  2a,  2b,  or 3  were  not <0.990.  The observed y absorbance 
values for each IgG subclass in the affinity-purified chick CII antibody preparations then 
were entered  into the calculator to compute the corresponding #g/ml values by solving 
for log x in this equation. 
lgG Autoantibody Subclass ELISA.  Arthritic mice were bled within 48 h after the onset 
of disease and nonarthritic  mice were bled at the peak of the serum response,  i.e.,  day 
40-45.  These two times were similar,  since the  mean onset day (+SE) for arthritic  D1 
mice (Table I) was 43 +  2, n  =  25. An exception to the above protocol is noted for the 
study described  in Table  IV. Serum samples werestored  at  -70°C  before assaying for 
IgG autoantibody  as  follows.  The  serum  samples  were  diluted  in  ELISA buffer  and 
incubated overnight at 4°C on microtiter plates coated with 2 ~zg/ml mouse CII in 0.145 
M  potassium  phosphate  buffer, pH  7.6.  Absorbance values for each  IgG subclass were 
developed  with  the  rabbit  anti-mouse  subclass  sera,  peroxidase-conjugated  goat  anti- 
rabbit  IgG  Fc-specific  serum,  and  peroxidase  substrate  as  described  above.  Known 
concentrations of anti-chick CII IgG1, 2a, 2b, and 3 in affinity-purified chick CII antibody 
preparations were assayed simultaneously. These concentrations were established by IgG 
subclass ELISA on goat anti-mouse F(ab')2-coated microtiter plates as described above. 
The resultant pairs of values (absorbance and #g/ml IgG antibody subclass) were subjected 
to  linear  regression  analysis  to  compute m  and  b  values  for each  subclass;  correlation 
coefficients (r values) for the relationship between  ELISA absorbance and #g/ml  IgG1, 
2a, 2b, or 3 were not <0.980. The observedy absorbance values for each IgG autoantibody 
subclass in individual serum samples then were entered into the calculator to compute the 
corresponding/~g/ml values. 
Competitive Inhibition ELISA.  Anti-chick CII IgG2a was purified  from an aliquot of 
D 1 anti-chick CII IgG with protein A-Sepharose CL-4B (Sigma Chemical Co.), according 
to the  general procedure described by Ey et al.  (12).  The following modifications were 
made. After eluting IgM and IgG1 with pH 6 buffer, the buffer pH was changed to 3.5, 
to elute IgG2a plus IgG2b plus IgG3. The pH of this mixture was readjusted to 5.5, the 
mixture loaded back onto the column, and IgG2a was eluted by washing the column with 
pH  5.5  buffer.  The  IgG2a eluate  was immediately  neutralized  with  1  M  Tris,  pH  8, 
concentrated  in  an Amicon cell,  and  dialyzed into  PBS.  Analysis of the  eluate  by IgG 
subclass ELISA revealed 97%  IgG2a. Horseradish peroxidase (type IV; Sigma Chemical 
Co.) then  was conjugated to the  IgG2a antibody with glutaraldehyde,  according to the 
method described by Avrameas et al.  (13).  Various concentrations of pooled D1  or B6 
chick  CII  antibody  were  incubated  with  the  coupled  antibody  in  mouse  CII-coated 
microtiter  wells  for  18  h  at  4°C  using a  volume of 0.1  ml/well;  concentrations  were 
established by IgG subclass ELISA using plates coated with goat anti-mouse IgG F(ab')2, 
as explained in the previous section. The plates then were washed and peroxidase substrate WATSON  AND  TOWNES  1881 
was  added.  Absorbances  were  measured  with  the  Microelisa  Auto  Reader.  Relative 
antibody  affinity was  defined  as  the  concentration  of uncoupled  D1  or  B6  antibody 
required to reduce the ELISA absorbance by 50%. 
Results 
Analysis of the IgG Autoantibody Subclass  Response  in the CII AIA-susceptible D1 
Strain.  The relationship  between susceptibility to CII AIA and the  magnitude 
of the total IgG autoantibody response in the D1 strain is shown in Table I. With 
variably increasing  amounts  of mycobacteria  used  in  the  adjuvant,  the  serum 
level  of  IgG  autoantibody  increased  from  an  average  of  14  gg/ml,  without 
mycobacteria, to a maximum of 789 #g/ml with 250 gg mycobacteria per mouse. 
Arthritis  failed  to  develop  in  mice  immunized  without  mycobacteria in  which 
serum levels varied between 8 and 29 #g/ml.  In mice immunized with mycobac- 
teria, arthritis  was found to be associated with serum levels of 81-1,943/~g/ml. 
Analysis of the IgG subclass response revealed that most of this IgG autoantibody 
was IgG2a, averaging 73%  of the  total IgG autoantibody (range,  45-97%;  n  = 
25).  It is interesting to note that a  high  percent of IgG2a autoantibody respon- 
siveness appears to be an inherent trait of the D 1 strain, since IgG2a autoantibody 
also was the predominant  IgG subclass in  the  nonarthritic  D1  mice immunized 
with or without mycobacteria, averaging 55% (range, 40-71%; n  =  9).  In terms 
of the magnitude of the IgG2a autoantibody response, susceptibility appeared to 
be  associated  with  a  response  of ~50  #g/ml  or  more,  since  the  lowest  serum 
IgG2a autoantibody  level associated with disease was 62 gg/ml and  the  highest 
level associated with the absence of disease was 44 ug/ml (Fig.  1). 
Comparison of  lgG Autoantibody Subclass Responses in Susceptible D 1 and Resistant 
B6  Strains.  As  shown  in  Fig.  1,  IgG1,  2b,  and  3  autoantibody  responses  of 
nonarthritic B6 mice generally overlapped those of arthritic D1  mice. In marked 
contrast,  there  was a  clear  separation  between  IgG2a autoantibody  responses: 
TABLE  I 
A Comparison of Arthritic and Nonarthritic IgG Autoantibody Serum Levels in D1 Mice 
Anti-mouse Cll IgG 
Arthri-  Mean percent (range)  Group (n)  tis  Total 
1  2a  2b  3 
~g/ml 
DI, (7)  -  14 (8-29)  28 (17-43)  55 (40-71)  14 (7-24)  3 (2-6) 
D12 (8)  +  364 (81-836)  16 (7-33)  69 (57-84)  12 (5-25)  3 (1-9) 
DI2 (1)  -  69  7  55  29  9 
DI~ (10)  +  420 (171-858)  14 (3-27)  67 (45-87)  9 (1-32)  10 (2-36) 
DI4 (7)  +  789 (260-1943)  12 (1-31)  83 (63-97)  3 (1-5)  2 (1-4) 
DI4 (1)  -  81  4  54  33  9 
Mice were immunized with 100 ug chick CII and either 0 (Dll), 10 (DI2), 100 (DI3), or 250 (D14) 
ttg mycobacteria in  1FA. Total and percent IgG autoantibody  subclass values were derived  from 
individual ttg/ml autoantihody  subclass values determined by IgG autoantibody  subclass ELISA on 
mouse CII-coated microtiter plates as explained in Materials and Methods. 1882 
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FIGURE  1.  Comparison of IgG autoantibody subclass responses of the CII AIA-susceptible 
D1  strain (Table 1) with those of the resistant B6 strain. Immunization schedule for D1  mice 
is described in the legend to Table 1. B6 mice were immunized with 100 #g chick CII and 250 
gg mycobacteria in IFA (B6-4). Serum IgG autoantibody subclass levels were determined by 
lgG  autoantibody subclass  ELISA  on  mouse  CII-coated  microtiter plates  as  explained in 
Materials and Methods. (0) Arthritic mice, (O) nonarthritic mice. 
TABLE  II 
Comparison of the Crossreactivity of Anti-Chick CII IgG Affinity Purified from the Pooled 
Serum of Arthritic D1 and Nonarthritic B6 Mice 
Percent crossreactivity of anti-chick CII lgG 
Group 
1  2a  2b  3 
D1  57 (50-64)  50 (48-51)  56 (55-57)  53 (50-55) 
B6  53 (46-63)  54 (48-60)  55 (47-64)  49 (44-55) 
Antibody was purified with chick CII-Sepharose and assayed on either mouse CII- or chick CII- 
coated ELISA plates as described in Materials and Methods. Data represent anti-mouse CII ELISA 
value divided by the anti-chick CII ELISA value multiplied by 100; values represent the mean (range 
of triplicate determinations). 
the maximal B6 IgG2a autoantibody response was 14 #g/ml (group mean, 8 gg/ 
ml)  compared  with  the  lowest  IgG2a  autoantibody  response  associated  with 
arthritis in D 1 mice, i.e., 62 ~g/ml, measured in an arthritic D 1 mouse immunized 
with  10 Izg mycobacteria. 
Crossreactivity  with Mouse CII of Antibodies from Susceptible  D1 and Resistant B6 
Strains.  Table I I examines whether the relative deficiency of the lgG2a autoan- 
tibody subclass response  of the  B6  strain  shown  in  Fig.  1  might  represent  a WATSON  AND  TOWNES  1883 
subclass-specific decrease in crossreactivity with mouse C II. Details of the method 
are  described  in  the  legend  to  Table  II.  As  shown,  there  were  no  major 
differences in  the relative crossreactivities of B6 anti-chick CII  IgG1,  2a,  2b, 
and 3. There also was no major difference in crossreactivity when comparisons 
were made  with  D1  anti-chick  CII  IgG1,  2a,  2b,  and  3.  The  overall  mean 
percent crossreactivity of D1  or B6 anti-chick CII IgG (%  IgG1  +  % IgG2a + 
%  IgG2b +  %  IgG3/4) was 54%  (range, 50-57%) and 53%  (range, 49-55%), 
respectively. 
Affinity  of Autoantibody from  Susceptible D1  and  Resistant  B6  Strains.  The 
relative affinities of D1 and B6 antibody for mouse CII were compared using a 
competitive  inhibition  ELISA  as  described  in  Materials  and  Methods.  The 
comparison  revealed  that  27  t~g/ml  of either  D1  or  B6  chick  CII  antibody 
inhibited by 50% the binding of peroxidase-labeled D1 anti-chick CII IgG2a to 
mouse CII-coated microtiter plates. The ranges for 50% inhibition in duplicate 
determinations were 26-27  ug/ml  for D1  antibody and  24-29  ~tg/ml for B6 
antibody. 
IgG Autoantibody Subclass Response in (B6D1)Fl Hybrids.  The suggested asso- 
ciation between susceptibility and the IgG2a autoantibody response was further 
examined in (B6D1)Ft hybrids. As shown in Table III, 12 of 12 B6D1 mice were 
high-percent IgG2a autoantibody responders (range, 50-95%).  In the four with 
arthritis, total IgG autoantibody levels ranged from 65 to 358 ug/ml. As a result 
of high-percent IgG2a autoantibody responsiveness, most of this autoantibody 
was IgG2a and serum levels of IgG2a autoantibody were within the range of 
arthritic D1  levels. Table  III also shows that, in 4  of 12  nonarthritic B6 mice, 
total  IgG autoantibody levels were similar to arthritic B6D1  levels (B6 range, 
70-182/~g/ml).  However, serum IgG2a autoantibody levels remained substan- 
tially below arthritic  B6D1  levels (B6  range,  6-14  ~g/ml) as a  result of low- 
percent IgG2a autoantibody responsiveness (B6 range, 6-16%). 
Comparison of lgG Autoantibody Subclass Responses in Arthritic and Nonarthritic 
B6 and BIO Mice.  A  study was designed to challenge the resistance of the B6 
strain by increasing the quantity of mycobacteria-containing CFA from 250 t~g/ 
mouse to 500 ug/mouse, boosting, and treating the mice with low-dose (10 mg/ 
kg) Cytoxan 2 d  before the primary and booster immunizations, in an attempt 
to reduce T  suppressor cell activity (14). As shown in Table IV, these treatments 
did not produce any major changes in  either the magnitude of the total  IgG 
autoantibody response or the relative IgG subclass distribution of the total IgG 
autoantibody response in most of the B6 mice. 
However, arthritis did develop in 2 of 20 of these mice, one that received the 
higher  dose  of CFA  and  the  other,  the  higher  dose  of CFA  plus  low-dose 
Cytoxan. Total  IgG autoantibody levels were markedly elevated (Table IV) in 
these arthritic mice, but most of the IgG autoantibody was IgG2b. Table IV also 
shows the results of a study with the B10 subline in which 1 of 12 mice developed 
arthritis with the lower dose of CFA (250 ~g/mouse). Again, total IgG autoan- 
tibody levels were increased, but  IgG2b and not  IgG2a was the predominant 
IgG autoantibody subclass. 
Comparison of IgG2a Autoantibody Responses in Strains  of Mice Differing in H-2 
and lg-1 Haplotypes and Susceptibility to CII AIA.  Table V  presents the IgG2a 1884  MURINE  COLLAGEN  II  AUTOIMMUNE  ARTHRITIS 
TABLE  III 
Comparison of Arthritic and Nonarthritic IgG Autoantibody Responses in 'B6D1)F1 Hybrids 
and B6 Mice 
Anti-mouse CII IgG 
Strain  Arthritis 
Total  IgG2a  IgG2a 
#g/ml  %  #g/ml 
B6D1  358  60  214  + 
B6D1  210  95  200  + 
B6D1  168  53  89  + 
B6D1  65  83  54  + 
B6D1  39  72  28 
B6D1  35  74  26 
B6D1  29  66  19 
B6D1  21  71  15 
B6D1  18  50  9 
B6D1  18  50  9 
B6D1  15  60  9 
B6D1  13  69  9 
B6  182  6  11 
B6  86  16  14 
B6  73  10  7 
B6  70  9  6 
Mice  were  immunized with  100  ttg  chick  CII  and  250  /~g  mycobacteria  m  IFA.  Serum  IgG 
autoantibody subclass levels were determined by IgG autoantibody subclass ELISA on mouse CII- 
coated  microtiter  plates as described  in  Materials and  Methods. Total  and  percent  IgG2a  were 
determined from  individual #g/ml values of IgG1,  2a,  2b,  and  3  (only those B6  mice with  total 
responses within the range of B6D1 responses are shown here; see Table IV for the analysis of all  12 
B6 mice). 
autoantibody response as a  simple mathematical  product of the #g/ml  value of 
total  IgG  autoantibody  and  the  percent  IgG2a  autoantibody.  H-2q/Ig-lc  D1 
mice  were  high-total  and  high-percent  lgG2a  responders,  resulting  in  IgG2a 
autoantibody serum levels of 62 #g/ml  or more in the arthritic  animals.  In the 
one of eight D1  mice that failed to develop arthritis,  the serum IgG2a autoanti- 
body level was 44 #g/ml. 
The H-2d/Ig-lc D2 strain also was a high-percent IgG2a responder, but a low- 
total  IgG  responder.  As  a  result,  IgG2a  autoantibody serum  levels reached  a 
maximum  of only  22  #g/ml  and  arthritis  was not  observed.  To  evaluate  the 
possibility of a  link  between high-percent  IgG2a  responsiveness and  the  H-2d 
haplotype, we analyzed the response of the B10.D2/n  strain,  which has the H- 
2d hapiotype of the  D2 strain  on the  B10 (Ig-lb) background.  Unlike  the  D2 
strain,  this H-2d congenic strain  was a  low-percent IgG2a responder,  similar to 
the B10 strain.  Both of these latter strains  also were low-total IgG responders, 
resulting  in  serum  IgG2a autoantibody levels that  failed to reach  arthritic  D1 
levels. The  8% value for incidence of disease in the B10 strain shown in Table 
V refers to the  1 of 12 mice that developed disease and markedly elevated levels 
of IgG2b autoantibody (Table IV). 
B6D1  Fl  hyrids (H-2 b/q,  Ig-1  b/c) were low-total IgG responders similar to WATSON  AND  TOWNES  1885 
TABLE  IV 
Comparison of Arthritic and Nonarthritic lgG Autoantibody Responses in B6 and B IO Mice 
Anti-mouse CII IgG 
Group (n)  Arthritis  Mean percent (range) 
pg/ml Total 
1  2a  2b  3 
B6* (12)  -  57 (17-182)  20 (3-60)  20 (6-44)  45 (16-73)  16 (6-39) 
B62 (9)  -  31 (19-65)  8(5-11)  14(11-21)  59.(49-68)  18(15-30) 
B6~ (1)  +  573  2  6  78  14 
B6~/CYT (9)  -  89 (29-166)  6 (2-10)  17 (7-25)  62 (48-85)  16 (6-30) 
B62/CYT (1)  +  555  4  4  88  4 
B10, (11)  -  19 (7-43)  11 (5-23)  24 (16-30)  50 (29-65)  17 (13-32) 
B10t (1)  +  122  2  13  78  7 
Mice were immunized with  100 pg chick CII and either 250 (B101) or 500 (B6~) pg mycobacteria 
in  IFA:  B6  mice  also  were  boosted  with  100  #g  chick  CII  in  IFA  80  d  after  the  primary 
immunization. Cytoxan (CYT) (10 mg/kg) was administered by the intraperitoneal route 2 d before 
the primary and booster immunizations; B6 mice were bled 15 d after the booster, 4 and 7 d before 
the onset of arthritis in two mice; B10 mice were immunized once and bled on day 44, 5 d after 
the onset of arthritis  in  one  mouse.  Total and  percent  IgG autoantibody  subclass  values were 
derived  from  individual  #g/ml  autoantibody  subclass  values  determined  by  IgG autoantibody 
subclass ELISA on mouse CII-coated microtiter plates, as explained in Materials and Methods. 
* Nonarthritic B6 mice immunized once with 100 pg chick CII and 250 pg mycobacteria in IFA and 
bled on day 44 (Fig. 1). 
TABLE  V 
Genetic Variation in the Total IgG Autoantibody Response, the Percent IgG2a Autoantibody 
Response, and Susceptibility to CII AIA 
Anti-mouse CII lgG [mean (range)] 
Strain (n)  H-2  Ig-1  Arthritis 
Total  IgG2a  IgG2a 
pg/ml  %  #g/ml  % 
D1 (8)  q  c  700 (81-1943)  79 (54-97)  560 (44-1448)  88 
D2 (6)  d  c  20 (8-47)  63 (47-82)  12 (5-22)  0 
BI0 (12)  b  b  27 (7-122)  24 (13-38)  5 (2-16)  8 
B10.D2/n (6)  d  b  6 (4-10)  38 (20-50)  2 (2-3)  0 
B6 (12)  b  b  57 (17-182)  20 (6-44)  8 (5-14)  0 
B6D1 (12)  b/q  b/c  82 (13-358)  67 (50-95)  57 (9-214)  33 
B6D1  ×  D1 (5)  --  --  840 (242-1231)  79 (70-85)  666 (187-970)  100 
SWR (8)  q  c  770 (121-2267)  79 (67-90)  626 (108-1945)  0 
Mice were immunized with 100 pg chick CII and 250 pg mycobacteria in IFA as described previously 
for DI (Table I), B10 (Table IV), B6 (Fig. 1), and B6D1 (Table llI) strains; serum IgG autoantibody 
subclass levels were determined by IgG autoantibody subclass ELISA on mouse Cll-coated microtiter 
plates  as described  in  Materials  and  Methods.  Total  and  percent  IgG2a  were determined  from 
individual #g/ml values of IgG1, 2a, 2b, and 3. 
the B6 parent  strain, but high-percent  IgG2a  responders  similar to the D1  parent 
strain.  In  those  B6D1  mice  at  the  upper  range  of  the  total  response,  IgG2a 
autoantibody  levels  were  in  the  range  of  arthritic  D1  levels  and  disease  was 1886  MURINE  COLLAGEN  II  AUTO1MMUNE  ARTHRITIS 
observed. In the five backcrosses to D1, total IgG responses were low in one and 
high in the other four, while the percent IgG2a response was high in all five. In 
the mouse with  low total  IgG autoantibody,  however, the  IgG2a autoantibody 
level was in the range of arthritic  D1  levels; disease was observed in this animal 
as it was in the other four. Based upon the responses of both the B6DI and D1 
backcrosses,  high-percent  IgG2a  responsiveness  appears  to  be  inherited  as  a 
dominant trait. 
Finally, the IgG2a autoantibody response of the resistant and C5-deficient (15) 
H-2q/Ig-lc  SWR  strain  was  compared  with  that  of the  D1  strain  (Table  V). 
Arthritis  was absent in all eight SWR mice, despite the induction of an autoim- 
mune response that was equivalent to that of arthritic  D1  mice in terms of total 
IgG autoantibody and percent IgG2a autoantibody. 
Discussion 
The results of this study demonstrate an important  role for the IgG autoanti- 
body  subclass  response  in  CII  AIA.  In  the  susceptible  D1  strain,  the  IgG 
autoantibody response consisted predominantly of the IgG2a subclass and, in the 
resistant  B6  strain,  the  IgG2a  autoantibody  subclass  response  was  relatively 
deficient, despite similar IgGl,  2b, and  3 autoantibody responses.  Estimates of 
B6 antibody crossreactivity and affinity for mouse CII were similar to those of 
D 1 antibody, indicating that these parameters were not relevant to resistance to 
arthritis in this strain.  In recent studies, B6 mice were found to readily develop 
arthritis  after passive transfer  of affinity-purified rat anti-CII antibody (unpub- 
lished data), which is thought  to consist primarily of the IgG2a subclass (5,  18). 
Studies by Farkas et al. (16) and Ey et al. (17) suggest that rat IgG2a and mouse 
IgG2a are similar,  since IgG2a from either species is the most potent activator 
of the  classical  complement  cascade,  with  lgG2b  being  less  potent  but  more 
effective  than  IgG1.  Thus,  this  passive  transfer  study  tends  to  rule  out  the 
possibility that resistance in the B6 strain was due to defects in humoral effector 
systems,  e.g.,  complement  component  deficiencies  and/or  inflammatory  cell 
defects, and  also provides  support  for  the  link  between susceptibility and  the 
IgG2a subclass.  In (B6D1)F1  hybrids, arthritis  developed only in  those animals 
with  IgG2a  autoantibody  responses  that  approximated  or  exceeded  those  in 
arthritic  D1  animals,  further supporting the importance of the IgG2a autoanti- 
body response in determining susceptibility to CII AIA. 
As additional  evidence for the potential pathogenicity of the IgG2a subclass, 
we recently found (6) that  purified  D1  IgG2a antibody will activate C5 to C5a 
when  bound  to  cartilage  in  vitro  and  that  C5-deficient  mice  are  resistant  to 
arthritis  by passive  transfer  of CII  antibody.  Thus,  the  failure  of B6  mice  to 
develop disease, despite the production  of total  IgG autoantibody levels within 
the range  of arthritic  D1  mice, might  be explained  by the relative decrease in 
this potent complement-activating subclass. 
Aside from the greater complement-activating potency of IgG2a,  it is also of 
interest  that  bound  immune  complexes consisting  of IgG2a  appear  to  be  the 
most potent activators of Fc receptor-bearing  macrophages  (19).  This  finding 
might  be  relevant  to  a  further  pathogenic  role  for  the  lgG2a  autoantibody WATSON AND TOWNES  1887 
subclass in promoting the activation of mononuclear cell/macrophage-like cells 
found in areas of cartilage erosion in CII AIA. 
It should be noted that IgG2b and  1 are not devoid of either complement- 
(17) or macrophage (19)-activating activity, but rather are less active than IgG2a. 
Thus, it would be reasonable to expect that CII AIA could be induced by either 
subclass, if a sufficient quantity is produced and binds to the articular cartilage. 
The  development of arthritis  in  three  otherwise  resistant  B6  and  B10  mice 
(Table IV) appears to represent evidence for such a possibility in the case of the 
IgG2b subclass. The recent report by Wooley et al. provides additional support 
for this possibility (20). 
The  finding  that  susceptibility  to  CII  AIA  is  linked  to  the  predominant 
response of a single IgG subclass, e.g., IgG2a or 2b, has relevance to immuno- 
regulatory mechanisms as well as to potential strategies for modulating diseases 
involving a particular autoantibody subclass. The regulation of IgG2a expression 
is  linked with  specific T  cell  mechanisms (21).  Modulation  of these potential 
subclass regulatory mechanisms in the D1  strain, for example, might provide a 
more selective immunosuppressive effect by not interfering with IgG1  or 3 (or 
IgE, A, etc.) antibody subclass responses to other antigens, e.g., bacterial, viral, 
tumor, etc. 
Analysis of the immunogenetics of the IgG2a autoantibody subclass response 
in Table V suggests that CII AIA represents a model of autoimmunity in which 
susceptibility is dependent upon  the interaction of both  MHC  and non-MHC 
genes. According to this model, MHC genes, specifically I-A genes, regulate the 
magnitude of the total IgG autoantibody response, and non-MHC genes, perhaps 
Igh-C genes, regulate the relative fraction of IgG autoantibody as IgG2a. Such 
a model was initially suggested by the dissociation of the magnitude of the total 
IgG  autoantibody  response  and  the  relative  percent  of IgG2a  autoantibody 
observed  in  the  D1-D2  and  B6-B6D1  comparisons  (Table  V).  The  general 
concept that  H-2  genes are involved in  regulating the magnitude of humoral 
responses is well established (22).  In the case of CII AIA, Wooley et al. (7) and 
Huse et al. (8) used H-2 recombinant strains of mice to suggest that susceptibility 
and the high (total) antibody response to CII in the D1 strain is linked to the I- 
Aq haplotype of the H-2 or MHC. 
The D2-B10.D2/n  comparison in Table V  provides the basis for suggesting 
that non-MHC genes might be involved in regulating the relative percent of total 
IgG autoantibody as IgG2a. The H-2d/Ig-lc D2 strain was a high-percent IgG2a 
autoantibody responder, while the H-2d/Ig-lb B10.D2/n congenic strain was a 
low-percent IgG2a autoantibody responder. Thus, high-percent IgG2a autoan- 
tibody responsiveness was not linked to the H-2 haplotype of the D2 strain. This 
trait also does not appear to be linked to the H-2 haplotype of the D1  strain, 
since  IgG2b  and  not  IgG2a  was  described as  the predominant  IgG  antibody 
subclass  in  the  H-2  congenic  B10.Q  strain  (20).  Both  of these  comparisons 
provide  strong  evidence  of a  link  between  the  percent  IgG2a  autoantibody 
subclass response and a non-MHC locus (or loci). 
Idiotypes and allotypes are known to be linked to immunoglobulin genes. We 
suggest  that  an  Igh-C  gene(s)  might be  involved  in  determining the  relative 
fraction of total lgG autoantibody as IgG2a. This suggestion is based upon the 1888  MURINE  COLLAGEN  11  AUTOIMMUNE ARTHRITIS 
finding that  (a) the percent  IgG2a autoantibody response differed in  H-2 con- 
genic strains (Table V, D2 vs. B10.D2/n), thereby suggesting linkage to a locus 
outside the  H-2  or MHC, and  (b) there  is a  link  between high-percent  IgG2a 
autoantibody responsiveness in  Ig-lc  D1,  D2,  and  SWR strains  (Table V).  An 
interesting  consequence  of Igh-C  gene  involvement  might  be  the  use of Ig-1 
allotypes  in  predicting  susceptibility  to  a  disease  involving  a  particular  IgG 
subclass such as IgG2a.  For example, in the case of an experimental disease like 
CII AIA, the presence of the Ig-lc allotype would predict high-percent  IgG2a 
autoantibody responsiveness and the possibility of disease. As shown in Table V, 
high-percent  IgG2a autoantibody responsiveness appears to be a dominant trait, 
so that high-percent IgG2a autoantibody responsiveness would be expected even 
in individuals heterozygous for the Ig-lc allotype. Of course, additional studies 
with allotype congenic strains  are needed to determine  if this trait  is linked  to 
the Igh-C locus, as well as to determine if this trait is associated with other Ig-1 
allotypes (Ig-la, d, e, etc.). 
In a  recent study, Wooley et al.  (23) noted that the D1  and SWR strains are 
both  H-2q  and  are  equally  immunoresponsive  to  CII,  yet  the  D1  strain  is 
susceptible to CII AIA, while the SWR strain  is resistant.  We analyzed the IgG 
autoantibody subclass response  of the  SWR strain  and,  as shown  in  Table  V, 
total  IgG  autoantibody and  percent  IgG2a  autoantibody responses  were high 
and essentially identical to those of the D 1 strain.  Based upon the demonstrated 
resistance  of C5-deficient  mice  to passively transferred  disease (6),  we suggest 
that resistance in the SWR strain is related to the fact that this strain is genetically 
deficient in C5 (15).  C5 is linked to the Hc locus, which probably is not within 
the MHC (24). Thus, susceptibility to CII AIA appears to be linked to two non- 
MHC  genes,  one  that  determines  the  availability  of C5  and  another  which 
ensures that a high percent of total IgG autoantibody is an appropriate comple- 
ment  activating  subclass,  and  to  an  MHC  gene  that  determines  the  overall 
magnitude of the IgG autoantibody response. 
The  data  in  Tables  III and  V  emphasize  that  none  of these genetic factors 
alone  is  sufficient  for disease.  The  8  of 12  B6D1  mice that  failed  to develop 
disease  were  high-percent  IgG2a  autoantibody  responders,  as  were  D2  mice. 
However, in these cases, total IgG autoantibody levels were too low, i.e.,  below 
the  lowest  IgG2a  autoantibody  level  associated  with  disease.  In  the  case  of 
nonarthritic  B6 mice,  total  responses were within  the range  of arthritic  B6D1 
levels, but the percent  IgG2a response was too low to ensure adequate  serum 
IgG2a autoantibody levels. Finally, the resistant SWR strain is both a high-total 
and a high-percent  IgG2a responder, but is genetically deficient in C5. 
In conclusion,  susceptibility to CII AIA can be regarded as a  complex inter- 
action  of multiple  MHC and  non-MHC  genes  that  control  not  only the  total 
humoral  response, but also the quality of this response, e.g.,  the IgG2 subclass 
as  well  as  the  availability  of mediators  of the  inflammatory  response  such  as 
complement C5. 
Summary 
Analysis of the IgG autoantibody subclass response in the collagen II autoim- 
mune arthritis  (CII AIA)-susceptible D1  strain  mice revealed that  the onset of WATSON  AND  TOWNES  1889 
disease was associated with a  predominance  of IgG2a autoantibody.  In a  com- 
parative study, resistance in the B6 strain was associated with a deficient IgG2a 
autoantibody response.  B6  IgG1,  2b,  and  3  autoantibody  responses generally 
overlapped those of arthritic  D 1 mice, and estimates of antibody crossreactivity 
and affinity were similar for both strains.  In crosses between D 1 and B6, arthritis 
developed only in those Fj mice with IgG2a autoantibody responses approximat- 
ing or exceeding those in arthritic D1 mice. Additional studies with B6 and B10 
strains suggested an alternate role for the IgG2b autoantibody response. 
In inbred strains with known genetic backgrounds, a dissociation between the 
magnitude  of the  total  IgG autoantibody response and  the percent  of total  as 
IgG2a was demonstrated.  The H-2q, Ig-lc D1  strain was a high-total and high- 
percent  IgG2a responder,  while the H-2d,  Ig-lc  D2 strain  was a  low-total but 
high-percent  IgG2a responder.  The  H-2b,  Ig-lb B6 strain  was a  low-total and 
low-percent IgG2a responder, while the H-2b/q, Ig-lb/c (B6D1)F~ hybrid was a 
low-total  but  high-percent  IgG2a  responder.  A  further  dissociation  between 
high-percent  IgG2a  autoantibody  responsiveness  and  the  H-2  hapiotype  was 
demonstrated  by the  H-2 congenic  B10.D2/n  (H-2d,  Ig-lb)  strain,  in  which a 
low-percent  IgG2a  response was observed to differ from the  D2 strain.  High- 
percent  IgG2a autoantibody responsiveness also appeared to be inherited  as a 
dominant trait based upon high responses in all (B6D1)F~ hybrids and backcrosses 
to D 1. These findings suggest that the H-2 haplotype is involved in the total IgG 
autoantibody  response  but  that  the  relative  fraction  of the  total  response  as 
IgG2a is independent of the H-2 haplotype and possibly related to Igh-C genes. 
C5-deficient SWR (H-2q, Ig-lc) mice were found to have a high total autoan- 
tibody response to mouse CII and  IgG2a comparable to arthritic  D1  mice, but 
these mice did not develop arthritis. 
Based  upon  these  observations,  we  conclude  that  susceptibility to  CII  AIA 
requires the interaction of multiple genes, both major histocompatibilty complex 
(MHC) and non-MHC, which influence the magnitude (total IgG) and the quality 
(IgG subclass) of the autoimmune  response and  the availability of appropriate 
mediators (C5) to initiate the inflammatory reaction. 
Received  for publication 15July 1985. 
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